Sarah R Delaney

The Present and Future of Lipid Testing in Cardiovascular Risk Assessment.

A. Remaley, D. Beriault, A. Wolska, 2023, Clinical chemistry.

Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications

D. Beriault, Ernest Wong, D. Werb, 2021, Harm Reduction Journal.

Drug checking services as a surveillance tool for clinical laboratories: Examining trends in the unregulated fentanyl supply.

D. Beriault, D. Werb, Difei Sun, 2022, Clinical biochemistry.

Bias in IGF-1 concentrations and interpretation across three different clinical laboratory assays.

L. Sepiashvili, D. Beriault, F. Leung, 2022, Clinical Biochemistry.